Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Return on Sales: 2015-2025

Historic Return on Sales for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to 0.03%.

  • Surgery Partners' Return on Sales rose 200.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.0% for FY2024, which is 500.0% down from last year.
  • Per Surgery Partners' latest filing, its Return on Sales stood at 0.03% for Q3 2025, which was up 200.0% from 0.05% recorded in Q2 2025.
  • Surgery Partners' Return on Sales' 5-year high stood at 0.09% during Q2 2023, with a 5-year trough of 0.05% in Q4 2024.
  • For the 5-year period, Surgery Partners' Return on Sales averaged around 0.03%, with its median value being 0.03% (2025).
  • In the last 5 years, Surgery Partners' Return on Sales skyrocketed by 800bps in 2021 and then plummeted by -1200bps in 2024.
  • Surgery Partners' Return on Sales (Quarter) stood at 0.07% in 2021, then tumbled by -53bps to 0.03% in 2022, then skyrocketed by 93bps to 0.06% in 2023, then crashed by -185bps to 0.05% in 2024, then surged by 157bps to 0.03% in 2025.
  • Its Return on Sales was 0.03% in Q3 2025, compared to 0.05% in Q2 2025 and 0.0% in Q1 2025.